Filtered By:
Condition: Thrombosis
Cancer: Brain Cancers
This page shows you your search results in order of date.
Order by Relevance | Date
Total 375 results found since Jan 2013.
Providing End-of-Life Care in the Community: What Are the Challenges in Malaysia?
J Hosp Palliat Care. 2022 Sep 1;25(3):133-137. doi: 10.14475/jhpc.2022.25.3.133.ABSTRACTA 72-year-old woman with metastatic lung cancer to bone and brain and with left external iliac vein thrombosis was under the care of a community palliative care provider. She experienced an acute pain crisis due to acute limb ischemia of the left lower limb. Goals-of-care discussions were held with the patient and her family; she prioritized symptom control and end-of-life care at home. The family and patient were aware of her short prognosis. Her complex pain was managed by the community palliative team, and her family was empowered to...
Source: Cancer Control - September 7, 2023 Category: Cancer & Oncology Authors: Yoke Yeng Leong Ednin Hamzah Sylvia McCarthy Zee Nee Lim Source Type: research
Microbial production of docosahexaenoic acid (DHA): biosynthetic pathways, physical parameter optimization, and health benefits
Arch Microbiol. 2023 Aug 29;205(9):321. doi: 10.1007/s00203-023-03666-x.ABSTRACTOmega-3 fatty acids, including docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and α-linolenic acid (ALA), are essential polyunsaturated fatty acids with diverse health benefits. The limited conversion of dietary DHA necessitates its consumption as food supplements. Omega-3 fatty acids possess anti-arrhythmic and anti-inflammatory capabilities, contributing to cardiovascular health. Additionally, DHA consumption is linked to improved vision, brain, and memory development. Furthermore, omega-3 fatty acids offer protection against vario...
Source: Archives of Microbiology - August 29, 2023 Category: Microbiology Authors: Naaz Abbas Sana Riaz Sania Mazhar Ramsha Essa Maria Maryam Yasar Saleem Quratulain Syed Ishrat Perveen Bakhtawar Bukhari Saira Ashfaq Syed Hussain Imam Abidi Source Type: research
Risk of recurrent cancer-associated venous thromboembolism: A Danish nationwide cohort study
CONCLUSIONS: Six-month recurrence risk after first-time cancer-associated venous thromboembolism was high and varied by cancer type and patient characteristics. Refining risk stratification for recurrence may improve decision-making regarding treatment duration after cancer-associated thromboembolism.PMID:37591413 | DOI:10.1016/j.ijcard.2023.131271
Source: Cancer Control - August 17, 2023 Category: Cancer & Oncology Authors: Anne Gulbech Ording Peter Br ønnum Nielsen Flemming Skj øth Thure Filskov Overvad Simon Noble Timothy L Lash Samuel Zachery Goldhaber Thomas Decker Christensen Torben Bjerregaard Larsen Mette S øgaard Source Type: research
Comment on: Silent Pulmonary Thromboembolism in Patients Undergoing Craniotomy for Brain Tumor
Turk Neurosurg. 2023;33(4):711. doi: 10.5137/1019-5149.JTN.44181-23.0.NO ABSTRACTPMID:37470514 | DOI:10.5137/1019-5149.JTN.44181-23.0
Source: Turkish Neurosurgery - July 20, 2023 Category: Neurosurgery Authors: Claudia Ni ño Darwin Cohen Daniel Ben ítez Jos é Daniel Guerra Source Type: research
Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study
CONCLUSION: One year after anticoagulant cessation for a cancer-associated VTE, about 10% of patients experienced a recurrence. Discontinuing anticoagulant therapy seems safe mainly in surgery-associated VTE.PMID:37068594 | DOI:10.1016/j.jtha.2023.04.010
Source: Thrombosis and Haemostasis - April 17, 2023 Category: Hematology Authors: Fran çois-Xavier Lapébie Alessandra Bura-Rivi ère Olivier Espitia Vanina Bongard Maurizio M Ciammaichella Jos é González Martínez Patricia Sig üenza Joaqu ín Castro Giménez Laurent Bertoletti Manuel Monreal Source Type: research
